|
|
|
| Clinical Value of Mobile Medicine in Standardized Management of Gestational Diabetes Mellitus |
| XUE Xiao-wen, LIU Li-da, ZHANG Ming-hui, et al |
| Department of Obstetrics and Gynecology, Pinggu District Hospital, Beijing 101200 |
|
|
|
|
Abstract 【Objective】To analyze the clinical value of mobile medicine in the standardized management of gestational diabetes mellitus (GDM). 【Methods】A total of 120 GDM patients admitted to Beijing Pinggu District Hospital from January 2018 to September 2019 were randomly divided into the observation group and the control group, with 60 cases in each group. Both groups were given routine GDM standardized management, while the observation group was added with WeChat-based mobile medical management. The management effect, pregnancy outcome and delivery outcome of the two groups were compared. 【Results】Two weeks and 4 weeks after management, the Fasting plasma glucose (FPG) and 2-hour postprandial blood glucose (2hPG) of the two groups were lower than before the management. The FPG and 2hPG compliance rates were higher than before the management. Both the 2hPG compliance rate after 2 weeks of management and the FPG and 2hPG compliance rates after 4 weeks of management in the observation group were higher than those of the control group (P＜0.05). The incidence of preeclampsia, the rate of cesarean section and the total time of labor in the observation group were lower than those in the control group; the difference was statistically significant (P<0.05). The incidence of hypoglycemia in newborns of the observation group was lower than that of the control group (P<0.05). 【Conclusion】The application of mobile medicine in the standardized management of GDM can significantly improve the effect of blood glucose control, improve the outcome of pregnancy and delivery.
|
|
Received: 10 January 2020
|
|
|
|
|
|
[1] Rigla M, Martínez-Sarriegui I, García-Sáez G, et al. Gestational diabetes management using smart mobile telemedicine[J].J Diabetes Sci Technol,2018, 12(2): 260-264.
[2] 苏日娜, 朱微微, 魏玉梅, 等. 北京地区妊娠期糖尿病发病情况及妊娠结局的回顾性调查[J].中华围产医学杂志, 2016, 19(5): 330-335.
[3] Campbell M R, Shokrani M. Diabetes management and future trends[J].Clin Lab Sci,2016, 29(2): 122-126.
[4] 葛月萍, 闫淑萍, 王淑靖, 等. 微信咨询在妊娠期糖尿病管理中的应用探索[J].中国实用护理杂志, 2017, 33(36): 2819-2822.
[5] Hod M, Kapur A, Sacks D A, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care [J].Int J Gynecol Obstet,2015, 131(S3): S173-S211.
[6] American Diabetes Association. Standards of medical care in diabetes—2016: summary of revisions[J].Diabetes Care,2016, 39(Supplement 1): S4-S5.
[7] 杨昱, 王昆, 刘超. 口服降糖药在妊娠期糖尿病中的使用[J].中国糖尿病杂志, 2017, 9(7): 468-470.
[8] Johnson QB, Berry DC. Impacting diabetes self-management in women with gestational diabetes mellitus using short messaging reminders[J].J Am Assoc Nurse Pract,2018, 30(6): 320-326.
[9] 赵明, 李光辉. 规范化管理和治疗的妊娠期糖尿病与巨大儿发生风险的关系研究[J].中国全科医学, 2016, 19(26): 3140-3143.
[10] Nicholson W K, Beckham A J, Hatley K, et al. The Gestational Diabetes Management System (GooDMomS): development, feasibility and lessons learned from a patient-informed, web-based pregnancy and postpartum lifestyle intervention[J].BMC Pregnancy Childbirth,2016, 16(1): 277.
[11] 陈海天, 崔俭俭, 王子莲. 妊娠期糖尿病的产后随访和管理:2018年美国妇产科医师学会和美国糖尿病协会指南相关内容解读[J].中华围产医学杂志, 2018, 21(10): 652-656.
[12] 刘乐桐, 李玲. 关于妊娠期糖尿病指南的思考[J].中国实用内科杂志, 2018, 38(6): 519-522.
[13] 张薇. 新产程标准对妊娠期糖尿病初产妇分娩结局的影响[J].中国实用护理杂志, 2017, 33(12): 914-917.
[14] 王司娥. 交互分析模式团体教育在妊娠期糖尿病患者中的应用效果[J].中华现代护理杂志, 2017, 23(26): 3379-3382.
[15] Sayakhot P, Carolan-Olah M. Sources of information on gestational diabetes mellitus, satisfaction with diagnostic process and information provision[J].BMC Pregnancy Childbirth,2016, 16(1): 287.
[16] 葛月萍.微信咨询在妊娠期糖尿病管理中的应用探索[J].中国实用护理杂志, 2017, 33(36): 2819-2822. |
|
|
|
2020, Vol. 37 
